All News

Reimbursement

Market Access and Reimbursement Q&A with AviadoBio CEO Lisa Deschamps
21 June 2022
Market Access and Reimbursement Q&A with AviadoBio CEO Lisa Deschamps
Lisa Deschamps, AviadoBio CEO and
Market Access and Reimbursement Q&A with Nicola Redfern
21 June 2022
Market Access and Reimbursement Q&A with Nicola Redfern
Phacilitate's Advanced Therapies Europe speaker
Market Access and Reimbursement Q&A with Vice President of Novartis, Tay Salimullah
21 June 2022
Market Access and Reimbursement Q&A with Vice President of Novartis, Tay Salimullah
Market Access Report 2022
1 June 2022
Market Access Report 2022
The Phacilitate team explores market
POPULAR NEWS ITEMS
Image
11 August 2022

GentiBio Collab with Bristol Myers Squibb to Pioneer Engineered Treg Therapies for IBD

Image
10 August 2022

Stevenage Bioscience Hub’s Lab Hotel Joined by Inspira Pharmaceuticals

Image
9 August 2022

Pfizer Acquire Global Blood Therapeutics for $5.4 Billion

Gene Therapy May Be More Cost Effective for Treating Haemophilia B Than Other Methods
7 June 2021
Gene Therapy May Be More Cost Effective for Treating Haemophilia B Than Other Methods
A team from St Jude
Phacilitate’s Advanced Therapies Week Postponed Until June 2021
28 September 2020
Phacilitate’s Advanced Therapies Week Postponed Until June 2021
Despite Phacilitate’s enthusiasm and wholehearted
Phacilitate’s Rebrand Reinforces Commitment to The Advanced Therapies Community
9 September 2020
Phacilitate’s Rebrand Reinforces Commitment to The Advanced Therapies Community
London, July 9th 2020 -
Enabling Patient Access to Personalised Cell Therapies Through Innovative Technologies
2 September 2020
Enabling Patient Access to Personalised Cell Therapies Through Innovative Technologies
Dr Ohad Karnieli talks to
Load more News
RECOMENDED TOPICS
Clinical Trials
Collaborations, Mergers & Acquisitions
Finance & Investment
Patient Access & Engagement
Regulatory & Standards
Reimbursement
Strategy
POPULAR NEWS ITEMS
Image

GentiBio Collab with Bristol Myers Squibb to Pioneer Engineered Treg Therapies for IBD

Image

Stevenage Bioscience Hub’s Lab Hotel Joined by Inspira Pharmaceuticals

Image

Pfizer Acquire Global Blood Therapeutics for $5.4 Billion